The quickest way to damage a company is to start believing it has a soul.
The drug developer who is certain he is saving lives. The software founder who knows she is democratizing access to something the world has been denied. These are not cynics or frauds at the outset. They are people answering what feels, to them, like a higher calling. And that is precisely what makes them dangerous.
A calling can inspire extraordinary work. It can also produce a form of cognitive dissonance that grows stronger the further reality drifts from belief. Leaders who feel they are answering a higher calling begin to feel exempt from ordinary accountability. Numbers lose meaning. Questions feel like betrayal. Conviction circulates like a hormone that keeps the system excited long after reason has left the room.
When the story of virtue becomes more important than the proof of results, conviction turns from energy into anesthesia.
Every collapse begins with conviction. Theranos wrapped itself in the language of access and public health. FTX claimed it was funding global good through effective altruism. Adam Neumann described his real estate venture as a spiritual awakening. In each case, moral language muffled the simplest questions: Where is the cash. Who decides. What happens if we are wrong.
Some companies managed to reverse course. Uber changed only after lawsuits and investor revolt forced a leadership overhaul. Meta rediscovered arithmetic after years of expensive distraction. Salesforce, under activist pressure, learned that efficiency is not cynicism. In every case, the correction came from outside the belief system. Governance restored what rhetoric had replaced.
A newer generation learned the same lesson through painful sincerity. Ørsted overextended into offshore wind projects that no longer made economic sense. Ford poured billions into electric vehicles before the market or the infrastructure was ready. These were not cynical efforts. They were genuine expressions of moral confidence, made reckless by motivated reasoning. Sincerity without analysis is still negligence.
But the most dangerous version of the trap is not the fraud. It is not Elizabeth Holmes, who knew she was lying. It is the founder who genuinely believes. The one whose compassion is real, whose conviction is earned, and whose thirty years of experience make it very difficult for anyone in the room to say what needs to be said.
When the Calling Takes the Chair
You are sitting on the board of a clinical-stage biotech company. The CEO is presenting. He is a physician. He has been treating cancer patients for thirty years. Before he became a CEO, he spent two decades in academic medicine, running clinical trials through a university department that bore his name. Sponsors funded those trials. He evangelized on their behalf. The work was real. The patients were real. And the money was always someone else's.
Now the money is yours. Or more precisely, it belongs to the investors whose capital you are responsible for overseeing.
The slide deck is dense with molecular diagrams and patient anecdotes. The science is elegant. The CEO presents it with the quiet authority of a man who has spent his career at the bedside. He is genuinely compassionate. You can feel it in the room. He is the kind of doctor you would want treating your own family.
Then someone asks about the burn rate.
The CEO's demeanor shifts. Not dramatically. A slight stiffening. He does not answer the question directly. Instead, he talks about the patients. "These patients have no alternatives," he says. "I have been treating them for thirty years. They are running out of options." He pauses. "If we stop this trial, we are abandoning them."
The room goes quiet. Nobody wants to be the person who argues with a doctor about dying patients. Nobody wants to be the one who says that compassion, however real, is not a financial plan. The physician's thirty years of clinical authority fill the room like a gas. It does not poison anyone. It just makes it very hard to breathe and ask a direct question at the same time.
His compassion is real. It is also making it very difficult to ask the question that needs to be asked.
You notice something. The CEO has never built the habit of critically evaluating his own clinical data. In academic medicine, he did not need to. The sponsors paid. The university provided the stamp of credibility. His role was to recruit patients and present results at conferences. That skill set does not transfer to a boardroom where the investors' money is running out and the data is not doing what the slide deck says it should.
When a board member presses on the endpoints, the CEO's tone sharpens. Not rudely. Politely. But with a precision designed to remind everyone that he is the physician in the room and they are not. He has done this before. It works. The board member retreats. The question dies. The trial gets extended. The treasury drains a little more.
His compassion is real. His frustration is real. He is still wrong. And the board just made a decision based on deference rather than evidence. That is the Higher Calling Trap at its most effective. It does not work through deception. It works through sincerity so convincing that questioning it feels like cruelty.
The Bill Campbell Antidote
Bill Campbell spent decades coaching leaders across technology and media. His genius was pairing care with confrontation. He believed that kindness without accountability was sentimentality, and accountability without care was cruelty.
He began meetings with a single question: "What are you trying to do, and how will you know when you have done it?" Purpose mattered, but it was not enough. Proof mattered more. He taught leaders to make decisions in the room rather than in whispers afterward, to treat feedback as signal rather than threat, and to keep the mission in service of the result rather than the other way around.
His approach remains the clearest antidote to moralized management. It turns good intentions back into coordination. It replaces self-righteousness with rhythm.
A Practical Test Before the Next Big Decision
If you lead a team, or sit on a board, run this test before the next big decision.
- Write the mission in one sentence. Then set it aside.
- List the three outcomes that would prove success. Use numbers, dates, and independent verification.
- Identify the person who can stop the project if those outcomes do not appear on time. Give that person real authority.
- Ask for the strongest argument against your position. Put that person in the room. Let them speak first.
- Decide how much you are willing to lose if you are wrong. Cap the exposure before the debate begins.
- If you still believe after all of that, proceed. If not, pause. You can care about the mission tomorrow.
Most of us learned the rule early. Show your work. Check your math. Admit when you are wrong. The most sophisticated governance system is only that rule written in corporate form.
The companies that forgot it built temples to conviction. The companies that remembered found their way back through numbers, accountability, and people with the authority to say no.
When the next leader tells you their company is a calling, ask for a balance sheet. Ask for a timeline. Ask who has the authority to stop the project. Care about the mission, but keep the arithmetic close.
A firm that measures survives. A firm that admits error learns. A firm that treats purpose as responsibility, not identity, endures.